Inventor
KELLY JOSEPH M
US38 patents
⚠️ This page may combine multiple inventors who share the name “KELLY JOSEPH M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
20 patentsUS5874442AFeb 23, 1999
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
SCHERING CORP129 citations99
US6372747B1Apr 16, 2002
Farnesyl protein transferase inhibitors
SCHERING CORP93 citations97
US6362188B1Mar 26, 2002
Farnesyl protein transferase inhibitors
SCHERING CORP85 citations97
US6894063B2May 17, 2005
Substituted urea neuropeptide Y Y5 Receptor antagonists
SCHERING CORP24 citations93
US6576639B1Jun 10, 2003
Compounds for the inhibition of farnesyl protein transferase
SCHERING CORP23 citations93
US6214828B1Apr 10, 2001
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
SCHERING CORP22 citations93
US5958939ASep 28, 1999
Tricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseases
SCHERING CORP26 citations92
US5703090ADec 30, 1997
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP33 citations92
US5684013ANov 4, 1997
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP35 citations92
US7807672B2Oct 5, 2010
Compounds that are ERK inhibitors
SCHERING CORP16 citations81
US6440989B2Aug 27, 2002
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
SCHERING CORP7 citations74
US6218401B1Apr 17, 2001
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
SCHERING CORP10 citations74
US6143758ANov 7, 2000
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP6 citations74
US5506236AApr 9, 1996
4-substituted pyrazoloquinoline derivatives
SCHERING CORP7 citations74
US6130229AOct 10, 2000
Tricyclic compounds having activity as RAS-FPT inhibitors
SCHERING CORP3 citations63
US5459146AOct 17, 1995
4-substituted pyrazoloquinoline derivatives
SCHERING CORP5 citations63
US7705153B2Apr 27, 2010
Bipiperdine derivatives useful as CCR3 antagonists
SCHERING CORP2 citations62
US6740661B2May 25, 2004
Farnesyl protein transferase inhibitors
SCHERING CORP2 citations62
US6800636B2Oct 5, 2004
Farnesyl protein transferase inhibitors
SCHERING CORP1 citations52
US5786480AJul 28, 1998
4-substituted pyrazoloquinoline derivatives
SCHERING CORP1 citations52
MCUBE INC
6 patentsUS9175963B2Nov 3, 2015
Dead reckoning based initialization of position and heading using discrete position indicators
MCUBE INC9 citations84
US8904410B2Dec 2, 2014
Methods and apparatus for mobile device event detection
MCUBE INC9 citations84
US9052203B2Jun 9, 2015
Methods and apparatus for low-cost inertial dead-reckoning using context detection
MCUBE INC5 citations73
US9179266B2Nov 3, 2015
Augmentation of indoor navigation methods and apparatus with map matching constraints
MCUBE INC3 citations63
US9179248B2Nov 3, 2015
Methods and devices for position determination using regional minimal residual estimation
MCUBE INC2 citations60
US10197587B2Feb 5, 2019
Device and method for using time rate of change of sensor data to determine device rotation
MCUBE INC0 citations42
(unassigned)
2 patentsAMERICAN HOME PROD
2 patentsMERCK SHARP & DOHME LLC
2 patentsUS12331044B2Jun 17, 2025
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection
MERCK SHARP & DOHME LLC0 citations51
US12281109B2Apr 22, 2025
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
MERCK SHARP & DOHME LLC0 citations51